Wordt geladen...
Anti-CTLA-4 therapy-associated granuloma annulare in chronic myelomonocytic leukemia
Immune checkpoint inhibitor (ICI) therapies activate the immune system to unmask cancer cells that the body might otherwise not detect. These cancer therapies alter the immune system at different “checkpoint” proteins such as PD-1, PD-L1, or CTLA-4 to better target tumor cells, but also have the pot...
Bewaard in:
| Gepubliceerd in: | Proc (Bayl Univ Med Cent) |
|---|---|
| Hoofdauteurs: | , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Taylor & Francis
2020
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7785184/ https://ncbi.nlm.nih.gov/pubmed/33456170 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/08998280.2020.1818165 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|